tiprankstipranks
BeOne Medicines (ONC)
NASDAQ:ONC
US Market
ONC
BeOne Medicines
RESEARCH TOOLSreports
Want to see ONC full AI Analyst Report?

BeOne Medicines (ONC) Ratios

861 Followers

BeOne Medicines Ratios

ONC's free cash flow for Q1 2026 was $0.89. For the 2026 fiscal year, ONC's free cash flow was decreased by $ and operating cash flow was $0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.64 3.41 1.80 2.32 3.55
Quick Ratio
 3.27 3.08 1.58 2.09 3.35
Cash Ratio
 2.67 2.49 1.19 1.75 2.63
Solvency Ratio
 0.17 0.11 -0.18 -0.35 -0.97
Operating Cash Flow Ratio
 0.71 0.62 -0.06 -0.64 -1.02
Short-Term Operating Cash Flow Coverage
 11.14 8.37 -0.17 -1.68 -4.55
Net Current Asset Value
$ 2.85B$ 2.41B$ 1.40B$ 1.94B$ 3.21B
Leverage Ratios
Debt-to-Assets Ratio
 0.24 0.24 0.18 0.16 0.09
Debt-to-Equity Ratio
 0.43 0.46 0.32 0.26 0.14
Debt-to-Capital Ratio
 0.30 0.31 0.24 0.21 0.12
Long-Term Debt-to-Capital Ratio
 0.27 0.29 0.05 0.05 0.05
Financial Leverage Ratio
 1.80 1.88 1.78 1.64 1.46
Debt Service Coverage Ratio
 3.88 2.52 -0.60 -1.71 -5.37
Interest Coverage Ratio
 12.79 7.68 0.00 0.00 0.00
Debt to Market Cap
 0.05 0.06 0.05 0.05 0.02
Interest Debt Per Share
 1.47 18.87 10.26 8.91 5.79
Net Debt to EBITDA
 -3.47 -4.13 3.90 2.00 1.90
Profitability Margins
Gross Profit Margin
87.17%87.49%84.41%84.55%79.77%
EBIT Margin
11.68%8.89%-14.91%-49.12%-126.40%
EBITDA Margin
13.93%11.54%-10.40%-45.55%-121.71%
Operating Profit Margin
11.96%8.37%-14.91%-49.12%-126.40%
Pretax Profit Margin
11.42%7.80%-13.99%-33.59%-138.50%
Net Profit Margin
8.93%5.37%-16.92%-35.86%-141.52%
Continuous Operations Profit Margin
8.93%5.37%-16.92%-35.86%-141.52%
Net Income Per EBT
78.22%68.83%120.97%106.77%102.18%
EBT Per EBIT
95.48%93.23%93.81%68.38%109.58%
Return on Assets (ROA)
6.00%3.50%-10.89%-15.19%-31.41%
Return on Equity (ROE)
12.10%6.58%-19.35%-24.93%-45.71%
Return on Capital Employed (ROCE)
10.20%7.03%-15.33%-30.23%-36.44%
Return on Invested Capital (ROIC)
7.82%4.74%-12.42%-25.67%-34.00%
Return on Tangible Assets
6.05%3.53%-11.13%-15.48%-31.88%
Earnings Yield
1.02%0.87%-3.32%-4.77%-8.83%
Efficiency Ratios
Receivables Turnover
 6.06 6.18 5.37 6.21 7.12
Payables Turnover
 1.74 1.40 1.47 1.21 0.97
Inventory Turnover
 1.08 1.10 1.20 0.91 1.01
Fixed Asset Turnover
 3.22 2.99 2.30 1.79 1.53
Asset Turnover
 0.67 0.65 0.64 0.42 0.22
Working Capital Turnover Ratio
 1.25 1.73 1.83 0.80 0.29
Cash Conversion Cycle
 187.92 129.63 123.22 155.81 35.45
Days of Sales Outstanding
 60.23 59.10 67.93 58.77 51.29
Days of Inventory Outstanding
 337.27 332.07 304.11 399.78 359.74
Days of Payables Outstanding
 209.59 261.54 248.82 302.74 375.58
Operating Cycle
 397.50 391.17 372.04 458.55 411.03
Cash Flow Ratios
Operating Cash Flow Per Share
 0.90 10.34 -1.34 -11.09 -14.51
Free Cash Flow Per Share
 0.76 8.63 -6.36 -16.80 -19.06
CapEx Per Share
 0.13 1.70 5.03 5.71 4.55
Free Cash Flow to Operating Cash Flow
 0.85 0.84 4.76 1.52 1.31
Dividend Paid and CapEx Coverage Ratio
 6.78 6.07 -0.27 -1.94 -3.19
Capital Expenditure Coverage Ratio
 6.78 6.07 -0.27 -1.94 -3.19
Operating Cash Flow Coverage Ratio
 0.63 0.56 -0.13 -1.24 -2.51
Operating Cash Flow to Sales Ratio
 0.22 0.21 -0.04 -0.47 -1.06
Free Cash Flow Yield
3.00%2.84%-3.44%-9.49%-8.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 98.44 115.48 -30.16 -20.96 -11.32
Price-to-Sales (P/S) Ratio
 6.37 6.20 5.10 7.51 16.02
Price-to-Book (P/B) Ratio
 10.62 7.60 5.84 5.22 5.17
Price-to-Free Cash Flow (P/FCF) Ratio
 33.33 35.18 -29.04 -10.54 -11.54
Price-to-Operating Cash Flow Ratio
 39.19 29.39 -138.29 -15.96 -15.16
Price-to-Earnings Growth (PEG) Ratio
 0.19 -0.18 1.09 0.37 -0.41
Price-to-Fair Value
 10.62 7.60 5.84 5.22 5.17
Enterprise Value Multiple
 42.30 49.59 -45.15 -14.49 -11.26
Enterprise Value
 34.00B 30.59B 17.90B 16.23B 19.41B
EV to EBITDA
 42.31 49.59 -45.15 -14.49 -11.26
EV to Sales
 5.89 5.72 4.70 6.60 13.71
EV to Free Cash Flow
 30.81 32.48 -26.73 -9.26 -9.87
EV to Operating Cash Flow
 26.27 27.13 -127.28 -14.03 -12.97
Tangible Book Value Per Share
 3.29 39.41 30.42 32.84 41.58
Shareholders’ Equity Per Share
 3.31 39.99 31.65 33.89 42.50
Tax and Other Ratios
Effective Tax Rate
 0.22 0.31 -0.21 -0.07 -0.02
Revenue Per Share
 4.00 48.99 36.19 23.55 13.73
Net Income Per Share
 0.36 2.63 -6.12 -8.45 -19.43
Tax Burden
 0.78 0.69 1.21 1.07 1.02
Interest Burden
 0.98 0.88 0.94 0.68 1.10
Research & Development to Revenue
 0.38 0.40 0.51 0.72 1.16
SG&A to Revenue
 0.37 0.39 0.48 0.00 0.00
Stock-Based Compensation to Revenue
 0.05 0.10 0.12 0.15 0.21
Income Quality
 2.51 3.93 0.22 1.31 0.75
Currency in USD